MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.27776
Abstract: Gastric adenocarcinoma is usually diagnosed in late stages, necessitating the use of different therapeutic modalities. Currently, antibody‐based therapies have also been approved through with limited clinical efficacy. Reinforcing antibody‐based immunotherapy by using chimeric antigen receptor… read more here.
Keywords: msln mesothelin; mesothelin antxr1; gastric adenocarcinoma; antxr1 tem8 ... See more keywords